[HTML][HTML] COVID-19 and diabetes mellitus: from pathophysiology to clinical management

S Lim, JH Bae, HS Kwon, MA Nauck - Nature Reviews Endocrinology, 2021 - nature.com
Initial studies found increased severity of coronavirus disease 2019 (COVID-19), caused by
infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), in patients …

[HTML][HTML] The role of inflammation in diabetes: current concepts and future perspectives

S Tsalamandris, AS Antonopoulos… - European cardiology …, 2019 - ncbi.nlm.nih.gov
Diabetes is a complex metabolic disorder affecting the glucose status of the human body.
Chronic hyperglycaemia related to diabetes is associated with end organ failure. The clinical …

Inflammasomes in neuroinflammatory and neurodegenerative diseases

S Voet, S Srinivasan, M Lamkanfi… - EMBO molecular …, 2019 - embopress.org
Neuroinflammation and neurodegeneration often result from the aberrant deposition of
aggregated host proteins, including amyloid‐β, α‐synuclein, and prions, that can activate …

Targeting the NLRP3 inflammasome in inflammatory diseases

MSJ Mangan, EJ Olhava, WR Roush… - Nature reviews Drug …, 2018 - nature.com
Danger signals are a hallmark of many common inflammatory diseases, and these stimuli
can function to activate the cytosolic innate immune signalling receptor NLRP3 (NOD-, LRR …

[PDF][PDF] ISPAD clinical practice consensus guidelines 2022: stages of type 1 diabetes in children and adolescents

REJ Besser, KJ Bell, JJ Couper, AG Ziegler… - Pediatric …, 2022 - endoped.ro
ISPAD clinical practice consensus guidelines 2022: Stages of type 1 diabetes in children and
adolescents Page 1 ISPAD GUIDELINES ISPAD clinical practice consensus guidelines 2022 …

[HTML][HTML] The effect of low-dose IL-2 and Treg adoptive cell therapy in patients with type 1 diabetes

S Dong, KJ Hiam-Galvez, CT Mowery, KC Herold… - JCI insight, 2021 - ncbi.nlm.nih.gov
BACKGROUND A previous phase I study showed that the infusion of autologous Tregs
expanded ex vivo into patients with recent-onset type 1 diabetes (T1D) had an excellent …

A guiding map for inflammation

MG Netea, F Balkwill, M Chonchol, F Cominelli… - Nature …, 2017 - nature.com
Biologists, physicians and immunologists have contributed to the understanding of the
cellular participants and biological pathways involved in inflammation. Here, we provide a …

Targeting innate immune mediators in type 1 and type 2 diabetes

MY Donath, CA Dinarello… - Nature Reviews …, 2019 - nature.com
Type 1 and type 2 diabetes are characterized by chronic inflammation; both diseases
involve pancreatic islet inflammation, while systemic low-grade inflammation is a feature of …

[PDF][PDF] New frontiers in the treatment of type 1 diabetes

JT Warshauer, JA Bluestone, MS Anderson - Cell metabolism, 2020 - cell.com
Type 1 diabetes is an autoimmune disease caused by the immune-mediated destruction of
pancreatic β cells that results in lifelong absolute insulin deficiency. For nearly a century …

[HTML][HTML] The role of interleukin-1 in general pathology

N Kaneko, M Kurata, T Yamamoto, S Morikawa… - Inflammation and …, 2019 - Springer
Abstract Interleukin-1, an inflammatory cytokine, is considered to have diverse physiological
functions and pathological significances and play an important role in health and disease. In …